North Macedonia vs Saint Barthélemy: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
North Macedonia
0.2%
in 2024
Saint Barthélemy
0.2%
in 2024
North Macedonia rank
98th
Saint Barthélemy rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- North Macedonia
- Saint Barthélemy
How they compare
North Macedonia currently reports 0.2% against 0.2% in Saint Barthélemy, a difference of 0.0%.
Across all 10 years both countries report, Saint Barthélemy has been ahead every year.
North Macedonia ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
Saint Barthélemy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Saint Barthélemy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.3% | 0.2% | Saint Barthélemy |
| 2020s | 0.1% | 0.2% | 0.1% | Saint Barthélemy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, North Macedonia or Saint Barthélemy?
- North Macedonia, at 0.2% against 0.2% in Saint Barthélemy as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between North Macedonia and Saint Barthélemy?
- 0.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Saint Barthélemy?
- 10 years are reported by both, from 2015 to 2024.
- How do North Macedonia and Saint Barthélemy rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- North Macedonia ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.